Articles 2021

The Federal Court’s decision in Sleep Country Canada Inc v Sears Canada Inc, granted a rather rare interlocutory injunction prohibiting the use of a slogan pending the final determination of a trademark infringement action. Sears Canada Inc. was enjoined from using their newly adopted slogan that stated “There is no reason to buy a mattress anywhere else”, as it was confusing to Sleep Country Canada Inc.’s (“Sleep Country”) trademarked slogan “Why buy a mattress anywhere else".

On June 30, 2017, the Supreme Court of Canada unanimously granted AstraZeneca’s appeal in the long-awaited conclusion of the “Promise Doctrine” saga in AstraZeneca Canada Inc v Apotex Inc. The primary legal consequence of this decision is that the Supreme Court of Canada has reset the utility test and eliminated the Promise Doctrine.

Amendments to the Trade-Marks Act made in 2014, despite not being fully implemented yet, have already encouraged squatting and over-claiming, and have resulted in a 75 per cent increase in the number of Canadian applications waiting to be registered, from 40,000 in 2014 to nearly 70,000, the CBA National IP Section says in a letter to Innovation, Science and Economic Development Canada.

The British Columbia Court of Appeal (BCCA) in Vancouver Community College v. Vancouver Career College (Burnaby) Inc. recently decided that use of a trademark as a keyword advertisement constituted passing off of a trademark, unanimously reversing the trial judge’s decision. The BCCA held that trademark confusion occurs at the moment the consumer first encounters the trademark in the search results, and not the moment the consumer clicks on the link and arrives at the landing page.

Significant legislative changes are on the horizon in the field of genetic testing with Parliament’s recent passage of Bill S-201: An Act to Prohibit and Prevent Genetic Discrimination. The Act will implement broad protections relating to an individual’s right to access their genetic information, as well as to prevent an individual from being required to undergo genetic testing and to disclose the results of their genetic tests. This article examines the legislative changes.

The Supreme Court of Canada heard oral arguments on November 8, 2016 in an important appeal challenging the “promise of the patent” utility doctrine in Canada. In AstraZeneca Canada Inc. v. Apotex Inc. (Esomeprazole), the Supreme Court was asked to decide on the question of whether the doctrine properly exists in Canada. This article provides a brief summary of the oral arguments heard by the Supreme Court.

John Simpson outlines the options available to companies experiencing an online attack on its brand.